Doctor
Prof. Dr. Raymond  Miralbell

Prof. Dr. Raymond Miralbell

Address: Carrer de Vilana, 12, 08022 Barcelona, Barcelona, Catalunya, Spain

Gender: Male

Type of Professional: Oncologist

Associated Healthcare Provider: QS Teknon Medical Center, Quirónsalud Proton Therapy Center

Languages Spoken: Catalan, English, French, German, Italian, Spanish

About the Doctor

Professor Dr. Raimon Miralbell is the Director of the Radiotherapy Oncology Service of the Teknon Oncology Institute, Chief of the Radio-oncology Services for the University Hospitals of Geneva in Switzerland and Professor at the Faculty of Medicine of the University of Geneva.

He has a Medical Doctor’s degree from the University of Geneva. Since 1997 he has studied at renowned European and North American Centers, of which worth mentioning is the Royal Marsden Hospital in Sutton-Surrey in the United Kingdom and the City of Hope National Medical Centre in Duarte, California, in the United States. A Doctor and researcher for the proton therapy project from 1987 to 1989 at the Massachusetts General Hospital and for the Harvard Cyclotron Laboratory at Harvard University, Cambridge in Boston, Massachusetts, his main research areas are prostate cancer, breast cancer, high precision radiotherapy techniques and radio-biological mathematical models on the response of cancer to radiation. He is a member and founder of the European Scientific Institute (ESI) tied to the Centre Européen de Recherche Nucléarie, CERN (European Organization for cancer research and treatment) where he develops and manages training programs and new radiotherapy technology research projects and he has been the President of the Swiss Proton Users Group. He has also been invited as a speaker at numerous national and international meetings. 

His main expertise and research domains in the field of radiation oncology are: 

  • Imaging for radiotherapy treatment planning of breast and prostate cancer
  • Treatment precision optimization through image guided radiotherapy
  • Biomathematical modeling of prostate cancer response to irradiation and fractionation sensitivity: ultra-hypofractionation as a dose escalation method.
  • Biomathematical modeling for salvage radiotherapy after post-irradiation local failure for prostate cancer
  • Stereotactic beam radiotherapy for prostate, gynecologic, ocular/orbital, and oligometastatic tumors
  • Proton therapy

More Information

Education: - Additional training at the Radiation Therapy Department at the Royal Marsden Hospital in Sutton-Surrey, UK (1983) - Internship at the Radiation Oncology Department of City of Hope National Medical Center in Duarte-California, US (1985) - Senior resident and clinical/research fellow at the Radiation Medicine Department, Harvard Cyclotron (1987-1989) International Fellowships: - Thesis: "Fibromatoses: D'une surveillance postchirurgicale à l'association de chirurgie et radiothérapie". Thesis # 9902. 1997. Academic degree of "Docteur en Médecine" (University of Geneva) - Thesis: "Potential role of proton beam therapy in pediatric brain tumors", 1996. Academic degree of "Privat Docent" (University of Geneva) Reviewer for the following peer-reviewed journals: Acta Neurochir, Acta Oncologica, Annals of Oncology, Bone Marrow Transpl, Brachytherapy, British Journal of Cancer, Cancer Detection Prevention, Cancer Investigation, Clinical Ophtalmology, Clinical Cancer Research, Critical Rew Oncol/Hematol, Frontiers in Oncology, Future Oncology, Int J Nanomedicine, Int J Radiat Oncol Biol Phys, Neurol India, Oncology, Radiation Oncology, Open Access Surgery, Radiation Research, Radiother Oncol, Technol Cancer Research Treat, The Lancet Oncology, The Oncologist.

Inquire Now